REGISTERED COMPANY NUMBER: 06268494 (England and Wales) REGISTERED CHARITY NUMBER: 1120756
REPORT OF THE TRUSTEES AND AUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 APRIL 2021
FOR
PULMONARY HYPERTENSION ASSOCIATION UK
Wyatt, Morris, Golland Ltd Statutory Auditors Park House 200 Drake Street Rochdale Lancashire OL16 1PJ
PULMONARY HYPERTENSION ASSOCIATION UK
CONTENTS OF THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 APRIL 2021
| Page | |||
|---|---|---|---|
| Reference and Administrative Details | 1 | ||
| Report of the Trustees | 2 | to | 9 |
| Report of the Independent Auditors | 10 | to | 12 |
| Statement of Financial Activities | 13 | ||
| Balance Sheet | 14 | ||
| Notes to the Financial Statements | 15 | to | 23 |
PULMONARY HYPERTENSION ASSOCIATION UK
REFERENCE AND ADMINISTRATIVE DETAILS FOR THE YEAR ENDED 30 APRIL 2021
TRUSTEES I J Armstrong K Yeowart S Townsley T Pannel
The trustees are collectively referred to as both the board of trustees and the Management Committee. They are also directors for the purposes of the Companies Act.
REGISTERED OFFICE Unit 1, Newton Business Centre Newton Chambers Road, Thorncliffe Park Chapeltown Sheffield S35 2PH
REGISTERED COMPANY NUMBER 06268494 (England and Wales) REGISTERED CHARITY NUMBER 1120756 AUDITORS Wyatt, Morris, Golland Ltd Statutory Auditors Park House 200 Drake Street Rochdale Lancashire OL16 1PJ FINANCE OFFICER S Clayton
Page 1
PULMONARY HYPERTENSION ASSOCIATION UK (REGISTERED NUMBER: 06268494)
REPORT OF THE TRUSTEES FOR THE YEAR ENDED 30 APRIL 2021
The trustees who are also directors of the charity for the purposes of the Companies Act 2006, present their report with the financial statements of the charity for the year ended 30 April 2021. The trustees have adopted the provisions of Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019).
OBJECTIVES AND ACTIVITIES
Objectives and aims
The main object of the charity is to raise awareness of pulmonary hypertension. Raising awareness is difficult to measure quantitatively making it difficult to accurately assess the performance of the charity. Detailed below is a synopsis of the year's activities and achievements which aim to demonstrate qualitatively how the charity goes about meeting its objectives of raising awareness and providing financial assistance in cases of need.
Awareness is raised through the provision of information and educational resources for sufferers of the said condition, their families, carers and members of the medical profession.
In addition the charity also provides relief of need of sufferers of the said condition, their families and carers through the provision of financial assistance towards, but not exclusively, respite care, travel grants and equipment grants at the discretion of the Executive committee, as and when resources allow.
Public benefit
We review our aims, objectives and activities each year. This review looks at what we achieved and the outcomes of our work in the previous 12 months. The review looks at the success of each key activity and the benefits they have brought to those groups of people we are set up to help. The review also helps us to ensure our aim, objectives and activities remained focused on our stated purposes. We have referred to the guidance contained in the Charity Commission's general guidance on public benefit when reviewing our aims and objectives and in planning our future activities. In particular, the management committee consider how planned activities will contribute to the aims and objectives they have set.
Grantmaking
Requests of £500 or under require an administrator signature, and from £500 to £2,000 need to be agreed by the administrator and a trustee. Grants are only paid to an individual and not an institution,
A monthly grant limited to £5,000 is set. If this is to be surpassed it must be agreed by 2 trustees plus the treasurer.
Requests for in-flight oxygen will be covered on request if resources allow. Only 1 claim allowed per patient per year. These grants will not be included in the £5,000 monthly limit calculation.
Travel insurance claims will be treated as normal grant requests.
Page 2
PULMONARY HYPERTENSION ASSOCIATION UK (REGISTERED NUMBER: 06268494)
REPORT OF THE TRUSTEES FOR THE YEAR ENDED 30 APRIL 2021
STRATEGIC REPORT
Achievement and performance
The last 12 months have seen a significant amount of activity, aimed at supporting our members through the COVID-19 pandemic whilst maintaining as much of our core activity as possible too.
This report details the work we have undertaken between 1st May 2020 and 30th April 2021.
PATIENT SERVICES AND SUPPORT
To help improve quality of life and wellbeing for patients, we continued funding the post of a physiotherapist within the specialist PH service at the Royal Brompton Hospital. This follows the successful funding of a physiotherapist post in the Sheffield service and allows more patients to benefit from this specialism.
We reviewed our partnership with Anxiety UK and decided that due to the development of our internal resources, we could offer a better-quality service that also represented better value for money. Our Listening Line service launched at the beginning of 2021, bringing our partnership with Anxiety UK to an end.
Our partnership with Turn2us continues to give members valuable advice and resources around financial matters.
We have expanded our online peer support forums with the addition of a group for carers, and helped set up a group for those who have lost someone due to PH. Membership of these groups, plus our flagship forum, has continued to grow.
Much of our support activity has been focused on the COVID-19 pandemic.
Our dedicated web area has been reviewed and updated daily in line with the twists and turns of the pandemic, acting as a central hub for trusted information for our members.
Regular infocasts (recorded interviews with PH professionals) have provided expert advice and reassurance, with excellent feedback received from members.
We have provided extensive support and guidance around the vaccination rollout, with a focus on accurate and balanced information in line with government guidance but tailored to our membership.
We produced mask exemption notices to help members communicate their exemption whilst out and about, and mental wellbeing tools such as a 28-day positivity calendar and a wellbeing journal.
Regular updates via our social media channels have kept members informed and engaged and as restrictions began to lift, we produced materials to support people worried about a return to 'normality.
Research conducted in the summer of 2020 found that members highly valued the support outlined above:
-
98% said they found the information provided by our website extremely or very useful
-
97% said they found our social media content extremely or very useful
-
88% said they found our telephone support extremely or very useful
-
94% said they found our email support extremely or very useful
-
95% said they found our infocasts extremely or very useful
PUBLICATIONS & RESOURCES
This year saw us produce and distribute numerous publications.
'Your benefits assessment toolkit' supports those currently going through or preparing for a benefit assessment, aimed at upskilling those navigating the welfare system to ensure a correct decision is made.
'Pregnancy and PH' was completed this year, a world-first in tackling this important but controversial subject. This valuable publication gives patients and their loved ones the most up to date and accurate information, plus multiple real experiences and stories.
We have engaged in the rigorous resource development process from the Patient Information Forum. We were successful in receiving their 'quality mark' in early 2021, proving that our materials go through a robust process to maintain high quality.
This year saw further reprints of our core publications PH & You, Medication & PH, and Financial Support: What could my family be entitled to?
Page 3
PULMONARY HYPERTENSION ASSOCIATION UK (REGISTERED NUMBER: 06268494)
REPORT OF THE TRUSTEES FOR THE YEAR ENDED 30 APRIL 2021
Between May 2020 and May 2021, four issues of Emphasis, our quarterly member magazine, were produced. Advertising revenue was generated during this time.
All of our publications and resources were made available to order for free from our website, and shipments were made to all of the specialist centres.
Because of the impact of the pandemic on using external services to create resources, the organisation has invested in equipment and training to enable in-house production of media including high quality video and audio and web-based training and presentations. This investment will benefit our members for years to come and ultimately save money on outsourcing.
ONLINE
Our online activity has continued at pace. We have continued to manage and update our suite of websites, including the ongoing development of phocusonlifestyle.org.
Phauk.org saw a huge increase in traffic due to COVID-19 and this year we began to build on that by reviewing all of the content and design to make it easier to navigate and more use-friendly for both visitors and our internal team. This modernising project will continue into next year.
We have continued to produce monthly e-newsletters for both members and the PH Professionals group, and a large number of videos have been produced throughout the year which have been used across our websites and social media channels.
Social media activity and engagement continues to increase. Facebook now has over 4000 followers and our newest channel, Instagram, has gained almost 500 followers in a short period of time. Our YouTube channel now has 250 subscribers and Twitter is up to over 1300 followers.
Our online shop has responded to member demand by selling numerous pieces of high quality merchandise, ranging from the very popular face masks to water bottles and newly-sourced items such as multiwraps and dog bandanas. Sales are helping to promote PH and generate a small amount of funds too.
AWARENESS RAISING AND FUNDRAISING
This year the PHA UK was chosen to join the European Lung Foundation's Patient Advisory Committee, allowing us to put the views and experiences of those living with PH in the UK onto a wider European agenda.
November saw our fifth annual PH Awareness Week, where we focused on raising awareness of PH as a rare condition.
We shared multiple video case studies and secured media coverage across the UK, including on TV and in national online newspapers. The week also saw the launch of our 'PHighter20' challenge, which saw great engagement.
Raising funds in tandem with raising awareness has been a key part of the PHA UK's activity this year.
In August, we launched 'Walk With Us', a walking challenge that members could complete on a route of their choice. The concept involved the PH community walking in tandem, wherever they were in the country, to feel a sense of belonging in a time of isolation due to the pandemic. Many of those who took part chose to fundraise too.
The initiative was launched in reaction to the cancellation of the British Transplant Games, where we were due to be sponsors of the walk event. As well as raising awareness and income, it helped promote health and wellbeing during the lockdown too.
We ran a Christmas card design competition over the summer months to engage members and give children especially something to focus on during a difficult time. This was very successful, with a number of high standard entries received which went on to sell very well. This helped raise awareness of PH and our organisation over the Christmas weeks, as well as income from sales.
The impact on 'organic' fundraising due to the pandemic led to use placing a member of our staff, whose job role involved fundraising administration, on furlough. At the same time, we invested time and resource into incentivising a return to fundraising when lockdown lifted by creating a fundraising pack that would support people with their efforts and maximise success. This comprehensive toolkit was launched in March and has proved very popular.
We have also raised awareness of PH and our organisation via promoting a successful award entry that saw Iain Armstrong named Respiratory Nurse of the Year by the British Journal of Nursing. PR activity including press releases secured widespread media coverage and there was high engagement with online content around the accolade.
RESEARCH
Page 4
PULMONARY HYPERTENSION ASSOCIATION UK (REGISTERED NUMBER: 06268494)
REPORT OF THE TRUSTEES FOR THE YEAR ENDED 30 APRIL 2021
In the summer of 2020, we conducted a major piece of research into the impact of the early stages of the COVID-19 pandemic on those with pulmonary hypertension.
The survey attracted 824 responses - the highest ever to a PHA UK survey - and highlighted the psychological and physical impact of shielding, as well perceptions of support.
The findings were disseminated via a printed report ('Shielded Voices'), video case studies and social media and underpinned our activity during PH Awareness Week.
We have also conducted a number of online surveys to gain insight for a number of areas, and produced reports into the findings:
-
In May 2020, we partnered with Professor Nick Morrell of the British Heart Foundation to conduct a survey into our members' information needs about genetics and PAH.
-
In September 2020, we conducted a survey into thoughts around apps for the management of healthcare needs.
-
In November 2020, we conducted two surveys around palliative care - one amongst members and one amongst specialist centres.
-
In December 2020, we partnered with researchers at the University of Sheffield to conduct a survey around a proposed new study into diagnosing systemic sclerosis-associated PH earlier.
-
In January 2021, we conducted a survey of PH professionals to discover how remote monitoring was being carried out across the specialist centres.
-
In March 2021, we conducted a survey amongst the BAME PH community to understand perceptions of the COVID-19 vaccine rollout.
-
Also in March 2021, we conducted a survey around home health monitoring equipment.
We have supported the UNIPHY research team by creating a logo and strapline for their work, and helping to recruit patients to shape their strategy.
A major research success story of this financial year has been our work with trainee psychologist Gregg Rawlings to trial an intervention for those with PH who struggle with anxiety. We supported by designing and producing a series of workbooks, promotion of the research and recruiting patients to the trial, which ran until February 2021. These workbooks can now be utilised by ourselves to support more members and we will be continuing to support the study by collecting more data as the year goes on.
In addition to the projects above, we have been working with specialist centres to plan a major piece of research to shape the specialist service over the next five years, and this will continue throughout the year.
SUPPORT AND EDUCATION FOR MEDICAL PROFESSIONALS
In addition to the research projects highlighted above, we have continued to provided bursaries for healthcare professionals to complete our medical education programme, 'Pulmonary Hypertension - diagnosis and management' to help them understand more about the condition.
We have begun looking into updating this now hugely successful online course, fact-checking, adding more resources, more tools for students to utilise and more content to reflect the understanding we now have around broader subjects like intimacy, pregnancy, welfare and lifestyle adaptations.
We have continued to provide ongoing support and secretarial input for the PH Professionals group - including hosting virtual meetings and producing monthly e-newsletters.
This year we also launched a dedicated website for the PH Professionals group (https://www.phprofessionals.org.uk/) to house resources like EmPHAsis-10, research papers and related content.
We have continued to offer educational and travel grants to clinical staff working within the field of PH.
Similar to our support for the PH Professionals group, this year we offered our services to the PH Physicians group, hosting virtual meetings and providing secretariat support.
CHARITY DEVELOPMENT
Page 5
PULMONARY HYPERTENSION ASSOCIATION UK (REGISTERED NUMBER: 06268494)
REPORT OF THE TRUSTEES FOR THE YEAR ENDED 30 APRIL 2021
We have continued to explore links and foster relationships with other charities, and to outsource comms and design support to enable our core staff team to focus on membership services.
In the coming years we expect our resource centre to continue to offer a valuable source of income due to the ability to rent out the meeting room.
If you have any questions about the contents of this overview, please email office@phauk.org
Financial review
Investment policy and objectives
The charity has invested in a portfolio of investments currently held in Aegon, managed by IEP Financial. Last year the investments were held in Fidelity Investments, managed by R T Williams Ltd (Independent Financial Advisers), but were transferred over in the year ended 30th April 2021to IEP Financial. The investments are valued at market value at the year end in the accounts.
Financial review and reserves policy
The financial position of the charity as at 30 April 2021 was showing:-
£ Unrestricted funds 1,320,656 Restricted funds 8,781 __ Total funds 1,329,437 =======
At 30 April 2021, Pulmonary Hypertension Association UK had free reserves of £393,388 and £900,000 of designated funds as follows:
-
Up to £250,000 towards the cost of academic/clinical research.
-
Up to £80,000 towards the funding of awareness activities including setting up an All Parliamentary Group.
-
Up to £350,000 towards the production of educational literature and Online content including, completion of ImPAHct survey and production of newsletters with the results for medical professionals and members, Listening to me, Listening to you publication, Provision of educational resources for patients with learning disabilities, PH Medical Education Programme, Educational needs of patients and caregivers in relation to end of life care, practical aspects of daily living with PH, welfare benefit advice and the like.
-
Up to £50,000 towards fundraising activities.
-
Up to £65,000 as a contingency reserve.
-
Up to £105,000 towards arranging patient & peer educational and support events that can be undertaken within the constraints arising from the pandemic.
Where funds set aside for research are subsequently spent the expenditure is inclusive of both the charity's own unrestricted funds and contributions from third party partners including industry.
Going concern
There are no material uncertainties about the charity's ability to continue as a going concern.
Review of risks
The trustees have a risk management strategy which comprises:
-
An annual review of the risks the charity may face;
-
The establishment of systems and procedures to mitigate those risks identified;
-
The implementation of procedures designed to minimise any potential impact on the charity should those risks materialise.
The major risk faced by the charity is a fall in donations. There are currently adequate reserves to allow the Trustees to take action should this occur. A key element in the management of financial risk is the provision of a reserves policy to enable, amongst other things, the funding of the proposed future developments. This is regularly reviewed by the Trustees.
Page 6
PULMONARY HYPERTENSION ASSOCIATION UK (REGISTERED NUMBER: 06268494)
REPORT OF THE TRUSTEES FOR THE YEAR ENDED 30 APRIL 2021
STRATEGIC REPORT
Register of trustee's interests
In order to provide clarity and to comply with advice from the Charity Commission on dealing with potential conflicts of interest the Pulmonary Hypertension Association UK wishes to make public a register of trustee's interest.
Mr Iain Armstrong, Chairman and Executive trustee is employed by Sheffield Teaching Hospitals NHS Trust. Pulmonary Hypertension Association pay Sheffield Teaching Hospitals NHS Trust quarterly for the secondment of Iain Armstrong's services. In addition Mr Armstrong receives consultancy fees from the charity.
Mrs Susan Townsley is a patient Trustee, and is entitled to claim up to £200 per year as reimbursement for the cost of oxygen during airline travel. This policy is open to all members of the Pulmonary Hypertension Association UK.
All Trustees can apply for grants from the charity as beneficiaries if the relevant charitable conditions are met.
Please see related party and trustees expenses notes in the accounts for more information.
The trustees have charity trustee liability insurance for the year ended 30th April 2021.
Future plans
It is envisaged that future developments would include: -
-
The provision of funding directed towards wide-ranging research into all aspects of PH.
-
The research and development of further educational literature relating to pulmonary hypertension for patients, carers, nurses, and others. We have and continue to fund research meeting and conferences for health care professionals working in the field of PH, these are both national and international in their makeup.
-
The provision of funding to the specialist PH centres for research and nursing staff and other support staff.
STRUCTURE, GOVERNANCE AND MANAGEMENT
Governing document
Pulmonary Hypertension Association UK is a company limited by guarantee, governed by its Memorandum and Articles of Association (company number 06268494) and registered with the charity commission (charity number 1120756).
Members of the company guarantee £1 in the event of the company being wound up. There are currently 4 members being the Charity Trustees
The Charitable Company's powers ("the powers") are:
In furtherance of the objects but not otherwise the Management Committee may exercise the following powers:
(i) power to raise funds and to invite and receive contributions provided that in raising funds the Management Committee shall not undertake any substantial permanent trading activities and shall conform to any relevant requirements of the law;
(ii) power to buy, take on lease or in exchange any property necessary for the achievement of the objects and to maintain and equip it for use;
(iii) power subject to any consents required by law to sell, lease or dispose of all or any part of the property of the Charitable Company;
(iv) power subject to any consents required by law to borrow money and to charge all or any part of the property of the Charitable Company with repayment of the money so borrowed;
(v) power to employ such staff (who shall not be members of the Management Committee) as are necessary for the proper pursuit of the objects and to make all reasonable and necessary provision for the payment of pensions and superannuation for staff and their dependants;
(vi) power to co-operate with other charities, voluntary bodies and statutory authorities operating in furtherance of the objects or of similar charitable purposes and to exchange information and advice with them;
(vii) power to establish or support any charitable trusts, associations or institutions formed for all or any of the objects;
(viii) power to appoint and constitute such advisory committees as the Management Committee may think fit;
(ix) power to do all such other lawful things as are necessary for the achievement of the objects;
(x) power to provide financial assistance towards research activities for members of the medical profession.
Page 7
PULMONARY HYPERTENSION ASSOCIATION UK (REGISTERED NUMBER: 06268494)
REPORT OF THE TRUSTEES FOR THE YEAR ENDED 30 APRIL 2021
STRUCTURE, GOVERNANCE AND MANAGEMENT Recruitment and appointment of new trustees
Appointment of the management committee is governed by the charitable company's memorandum and articles.
The directors of the company are also charity trustees for the purposes of charity law and are known as members of the Management Committee. Under the requirements of the Memorandum and Articles of Association at each annual general meeting one third of the trustees are subject to retirement by rotation and may be re-elected.
All members of the Management committee give their time voluntarily and received no benefits from the charity. Any expenses reclaimed from the charity are set out in note 9 to the accounts.
Training of charity trustees is in accordance with advice published by the charity commission.
Decision making is carried out democratically during regular trustee meetings, held at least annually. Major decisions are documented in meeting minutes which are held by the secretary. Minutes are circulated to trustees before being signed off.
Organisational structure
Shaun Clayton (Director of Membership Support) is delegated to deal with the day to day management of the charity after discussions with the trustees.
Related parties
Due to the nature of the charity's operations and the composition of the Board of Trustees being drawn from local and national public and private sector organisations, it is inevitable that transactions will take place with organisations in which a member of the board of trustees may have an interest. Any such transactions are conducted at arm's length and in accordance with the charity's financial regulations and normal procurement procedures.
On 31 July 2010 the net assets and operations of Pulmonary Hypertension Association (UK), a unincorporated registered charity (charity number 1082613) were transferred to the charity at net book value.
The trustees of Pulmonary Hypertension Association UK are also trustees of Pulmonary Hypertension Association (UK).
Donations totalling £214,632 were made to the charity by Pulmonary Hypertension Association (UK) (2020 - £232,489).
At 30th April 2021, £20,693 was due from Pulmonary Hypertension Association (UK) (2020 - £26,061).
Details of Trustee's interests are summarised below;
In order to provide clarity and to comply with advice from the Charity Commission on dealing with potential conflicts of interest the Pulmonary Hypertension Association UK wishes to make public a register of trustee's interest.
Mr Iain Armstrong, Chairman and Executive trustee is employed by Sheffield Teaching Hospitals NHS Trust.
Mr Iain Armstrong receives remuneration from Pulmonary Hypertension Association UK for consultancy. Pulmonary Hypertension UK pays Sheffield Teaching Hospitals NHS Trust for Mr Armstrong's services other than those as a trustee.
Mrs Susan Townsley is a Patient Trustee, and is entitled to claim up to £200 per year as reimbursement for the cost of oxygen during airline travel. This policy is open to all members of the Pulmonary Hypertension Association UK.
STATEMENT OF TRUSTEES' RESPONSIBILITIES
The trustees (who are also the directors of Pulmonary Hypertension Association Uk for the purposes of company law) are responsible for preparing the Report of the Trustees and the financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice).
Company law requires the trustees to prepare financial statements for each financial year which give a true and fair view of the state of affairs of the charitable company and of the incoming resources and application of resources, including the income and expenditure, of the charitable company for that period. In preparing those financial statements, the trustees are required to
-
select suitable accounting policies and then apply them consistently;
-
observe the methods and principles in the Charity SORP;
-
make judgements and estimates that are reasonable and prudent;
-
prepare the financial statements on the going concern basis unless it is inappropriate to presume that the charitable company will continue in business.
Page 8
PULMONARY HYPERTENSION ASSOCIATION UK (REGISTERED NUMBER: 06268494)
REPORT OF THE TRUSTEES FOR THE YEAR ENDED 30 APRIL 2021
STATEMENT OF TRUSTEES' RESPONSIBILITIES - continued
The trustees are responsible for keeping proper accounting records which disclose with reasonable accuracy at any time the financial position of the charitable company and to enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the charitable company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.
In so far as the trustees are aware:
-
there is no relevant audit information of which the charitable company's auditors are unaware; and
-
the trustees have taken all steps that they ought to have taken to make themselves aware of any relevant audit information and to establish that the auditors are aware of that information.
AUDITORS
The auditors, Wyatt, Morris, Golland Ltd, will be proposed for re-appointment at the forthcoming Annual General Meeting.
Report of the trustees, incorporating a strategic report, approved by order of the board of trustees, as the company directors, on 10 December 2021 and signed on the board's behalf by:
I J Armstrong - Trustee
Page 9
REPORT OF THE INDEPENDENT AUDITORS TO THE TRUSTEES OF PULMONARY HYPERTENSION ASSOCIATION UK
Opinion
We have audited the financial statements of Pulmonary Hypertension Association Uk (the 'charitable company') for the year ended 30 April 2021 which comprise the Statement of Financial Activities, the Balance Sheet and notes to the financial statements, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice).
In our opinion the financial statements:
-
give a true and fair view of the state of the charitable company's affairs as at 30 April 2021 and of its incoming resources and application of resources, including its income and expenditure, for the year then ended;
-
have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and
-
have been prepared in accordance with the requirements of the Companies Act 2006.
Basis for opinion
We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditors' responsibilities for the audit of the financial statements section of our report. We are independent of the charitable company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC's Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.
Conclusions relating to going concern
In auditing the financial statements, we have concluded that the trustees' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.
Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the charitable company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.
Our responsibilities and the responsibilities of the trustees with respect to going concern are described in the relevant sections of this report.
Other information
The trustees are responsible for the other information. The other information comprises the information included in the Annual Report, other than the financial statements and our Report of the Independent Auditors thereon.
Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.
In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact. We have nothing to report in this regard.
Matters on which we are required to report by exception
We have nothing to report in respect of the following matters where the Charities (Accounts and Reports) Regulations 2008 requires us to report to you if, in our opinion:
-
the information given in the Report of the Trustees is inconsistent in any material respect with the financial statements; or
-
the charitable company has not kept adequate accounting records; or
-
the financial statements are not in agreement with the accounting records and returns; or
-
we have not received all the information and explanations we require for our audit.
Responsibilities of trustees
As explained more fully in the Statement of Trustees' Responsibilities, the trustees (who are also the directors of the charitable company for the purposes of company law) are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the trustees determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.
In preparing the financial statements, the trustees are responsible for assessing the charitable company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the trustees either intend to liquidate the charitable company or to cease operations, or have no realistic alternative but to do so.
Page 10
REPORT OF THE INDEPENDENT AUDITORS TO THE TRUSTEES OF PULMONARY HYPERTENSION ASSOCIATION UK
Our responsibilities for the audit of the financial statements
We have been appointed as auditors under Section 144 of the Charities Act 2011 and report in accordance with the Act and relevant regulations made or having effect thereunder.
Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue a Report of the Independent Auditors that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.
Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below:
The extent to which the audit was considered capable of detecting irregularities including fraud.
Our approach to identifying and assessing the risks of material misstatement in respect of irregularities, including fraud and non-compliance with laws and regulations, was as follows:
-the engagement partner ensured that the engagement team collectively had the appropriate competence, capabilities and skills to identify or recognise non-compliance with applicable laws and regulations;
-we identified the laws and regulations applicable to the company through discussions with directors and other management, and from our commercial knowledge and experience of charities;
-we focused on specific laws and regulations which we considered may have a direct material effect on the financial statements or the operations of the charity, including the Charities Act 2011and Companies Act 2006 and
-we assessed the extent of compliance with the laws and regulations identified above through making enquiries of management and inspecting legal correspondence where necessary,
-identified laws and regulations were communicated within the audit team regularly and the team remained alert to instances of non-compliance throughout the audit.
We assessed the susceptibility of the charity's financial statements to material misstatement, including obtaining an understanding of how fraud might occur, by:
-making enquiries of management as to where they considered there was susceptibility to fraud, their knowledge of actual, suspected and alleged fraud and
-considering the internal controls in place to mitigate risks of fraud and non-compliance with laws and regulations.
To address the risk of fraud through management bias and override of controls, we:
-performed analytical procedures to identify any unusual or unexpected relationships;
-tested journal entries to identify unusual transactions;
-assessed whether judgements and assumptions made in determining the accounting estimates were indicative of potential bias; and
-investigated the rationale behind significant or unusual transactions.
In response to the risk of irregularities and non-compliance with laws and regulations, we designed procedures which included, but were not limited to:
-agreeing financial statement disclosures to underlying supporting documentation;
-enquiring of management as to actual and potential litigation and claims; and
-reviewing correspondence with HMRC.
There are inherent limitations in our audit procedures described above. The more removed that laws and regulations are from financial transactions, the less likely it is that we would become aware of non-compliance. Auditing standards also limit the audit procedures required to identify non-compliance with laws and regulations to enquiry of the directors and other management and the inspection of regulatory and legal correspondence, if any.
Page 11
REPORT OF THE INDEPENDENT AUDITORS TO THE TRUSTEES OF PULMONARY HYPERTENSION ASSOCIATION UK
Material misstatements that arise due to fraud can be harder to detect than those that arise from error as they may involve deliberate concealment or collusion.
A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council's website at www.frc.org.uk/auditorsresponsibilities. This description forms part of our Report of the Independent Auditors.
Use of our report
This report is made solely to the charitable company's trustees, as a body, in accordance with Part 4 of the Charities (Accounts and Reports) Regulations 2008. Our audit work has been undertaken so that we might state to the charitable company's trustees those matters we are required to state to them in an auditors' report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the charitable company and the charitable company's trustees as a body, for our audit work, for this report, or for the opinions we have formed.
Wyatt, Morris, Golland Ltd Statutory Auditors Eligible to act as an auditor in terms of Section 1212 of the Companies Act 2006 Park House 200 Drake Street Rochdale Lancashire OL16 1PJ
10 December 2021
Page 12
PULMONARY HYPERTENSION ASSOCIATION UK
STATEMENT OF FINANCIAL ACTIVITIES FOR THE YEAR ENDED 30 APRIL 2021
| Notes INCOME AND ENDOWMENTS FROM Donations and legacies Investment income 2 Total EXPENDITURE ON Raising funds Charitable activities Charitable activities Total Net gains on investments NET INCOME/(EXPENDITURE) Transfers between funds 12 Net movement in funds RECONCILIATION OF FUNDS Total funds brought forward TOTAL FUNDS CARRIED FORWARD |
2021 Unrestricted Restricted Total funds funds funds £ £ £ 447,278 24,963 472,241 4,831 - 4,831 452,109 24,963 477,072 33,940 - 33,940 390,890 123,095 513,985 424,830 123,095 547,925 261,781 - 261,781 289,060 (98,132) 190,928 (47,214) 47,214 - 241,846 (50,918) 190,928 1,078,810 59,699 1,138,509 1,320,656 8,781 1,329,437 |
2020 Total funds £ 473,019 191 473,210 42,442 632,347 674,789 5,044 (196,535) - (196,535) 1,335,044 1,138,509 |
|---|---|---|
The notes form part of these financial statements
Page 13
PULMONARY HYPERTENSION ASSOCIATION UK (REGISTERED NUMBER: 06268494)
BALANCE SHEET 30 APRIL 2021
| Notes FIXED ASSETS Tangible assets 7 Investments 8 CURRENT ASSETS Stocks 9 Debtors 10 Cash at bank and in hand CREDITORS Amounts falling due within one year 11 NET CURRENT ASSETS TOTAL ASSETS LESS CURRENT LIABILITIES NET ASSETS FUNDS 12 Unrestricted funds Restricted funds TOTAL FUNDS |
Unrestricted funds £ 27,268 1,208,251 1,235,519 9,789 46,399 164,711 220,899 (135,762) 85,137 1,320,656 1,320,656 |
Restricted funds £ - - - - - 8,781 8,781 - 8,781 8,781 8,781 |
2021 Total funds £ 27,268 1,208,251 1,235,519 9,789 46,399 173,492 229,680 (135,762) 93,918 1,329,437 1,329,437 1,320,656 8,781 1,329,437 |
2020 Total funds £ 16,441 953,620 970,061 20,026 129,625 131,313 280,964 (112,516) 168,448 1,138,509 1,138,509 1,078,810 59,699 1,138,509 |
|---|---|---|---|---|
The charitable company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 April 2021.
The members have not deposited notice, pursuant to Section 476 of the Companies Act 2006 requiring an audit of these financial statements.
The trustees acknowledge their responsibilities for
(a) ensuring that the charitable company keeps accounting records that comply with Sections 386 and 387 of the Companies Act 2006 and
(b) preparing financial statements which give a true and fair view of the state of affairs of the charitable company as at the end of each financial year and of its surplus or deficit for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the charitable company.
These financial statements have been audited under the requirements of Section 145 of the Charities Act 2011.
These financial statements have been prepared in accordance with the provisions applicable to charitable companies subject to the small companies regime.
The financial statements were approved by the Board of Trustees and authorised for issue on 10 December 2021 and were signed on its behalf by:
I J Armstrong - Trustee
The notes form part of these financial statements
Page 14
PULMONARY HYPERTENSION ASSOCIATION UK
NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 APRIL 2021
1. ACCOUNTING POLICIES
Basis of preparing the financial statements
The financial statements of the charitable company, which is a public benefit entity under FRS 102, have been prepared in accordance with the Charities SORP (FRS 102) 'Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019)', Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act 2006. The financial statements have been prepared under the historical cost convention, with the exception of investments which are included at market value, as modified by the revaluation of certain assets.
The trustees consider that there are no material uncertainties about the Charity's ability to continue as a going concern.
Critical accounting judgements and key sources of estimation uncertainty
In the process of applying the entity's accounting policies management have not made any judgements that would have a significant effect on the amounts recognised in the financial statements. No estimations have been made that would have a significant risk of causing a material adjustment to the carrying amounts of assets and liabilities within the next financial year.
Income
All income is recognised in the Statement of Financial Activities once the charity has entitlement to the funds, it is probable that the income will be received and the amount can be measured reliably.
Expenditure
Liabilities are recognised as expenditure as soon as there is a legal or constructive obligation committing the charity to that expenditure, it is probable that a transfer of economic benefits will be required in settlement and the amount of the obligation can be measured reliably. Expenditure is accounted for on an accruals basis and has been classified under headings that aggregate all cost related to the category. Where costs cannot be directly attributed to particular headings they have been allocated to activities on a basis consistent with the use of resources.
Grants offered subject to conditions which have not been met at the year end date are noted as a commitment but not accrued as expenditure.
Allocation and apportionment of costs
The costs are allocated between each relevant fund as directed by the trustees. Costs are apportioned to match the correct period to which they relate.
Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Fixtures and fittings - 15% on reducing balance Office equipment - 25% on reducing balance
At each balance sheet date, the Charity reviews the carrying amounts of its property, plant and equipment to determine whether there is any indication that any items of property, plant and equipment have suffered an impairment loss. If any such indication exists, the recoverable amount of an asset is estimated in order to determine the extent of the impairment loss, if any. Where it is not possible to estimate the recoverable amount of the assets, the Company estimates the recoverable amount of the cash-generating unit to which the asset belongs.
If the recoverable amount of an asset is estimated to be less that its carrying amount, the carrying amount of the asset is reduced to its recoverable amount. Impairment loss is recognised as an expense immediately.
Where an impairment loss subsequently reverses, the carrying amount of the asset is increased to the revised estimate of its recoverable amount and would have been determined (net of depreciation) had no impairment loss be recognised for the asset in prior years. A reversal of an impairment loss is recognised as income immediately.
Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.
Taxation
The charity is exempt from corporation tax on its charitable activities.
Fund accounting
Unrestricted funds can be used in accordance with the charitable objectives at the discretion of the trustees.
Page 15
continued...
PULMONARY HYPERTENSION ASSOCIATION UK
NOTES TO THE FINANCIAL STATEMENTS - continued FOR THE YEAR ENDED 30 APRIL 2021
1. ACCOUNTING POLICIES - continued
Fund accounting
Restricted funds can only be used for particular restricted purposes within the objects of the charity. Restrictions arise when specified by the donor or when funds are raised for particular restricted purposes.
Further explanation of the nature and purpose of each fund is included in the notes to the financial statements.
Pension costs and other post-retirement benefits
The charitable company operates a defined contribution pension scheme. Contributions payable to the charitable company's pension scheme are charged to the Statement of Financial Activities in the period to which they relate.
Government grants - covid 19
Government grants are recognised when there is reasonable assurance that the company will comply with the conditions attaching to the grant and the grant will be received.
Following the outbreak of the Covid-19 Pandemic the company furloughed members of staff and took advantage of the government job retention scheme. Grant income is accrued for in the period matching the period the wages were due for.
Financial instruments
Debtors
Trade and other debtors are recognised at the settlement amount due after any trade discount offered. Prepayments are valued at the amount prepaid net of any trade discounts due.
Cash at bank and in hand
Cash at bank and in hand includes cash and short term highly liquid investments with a short maturity of three months or less from the date of acquisition or opening of the deposit or similar account.
Creditors and provisions
Creditors and provisions are recognised where the company has a present obligation resulting from a past event that will probably result in the transfer of funds to a third party and the amount due to settle the obligation can be measured or estimated reliably. Creditors and provisions are normally recognised at their settlement amount after allowing for any trade discounts due.
Financial Instruments
The company only has financial assets and financial liabilities of a kind that qualify as basic financial instruments. Basic financial instruments are initially recognised at transaction value and subsequently measured at their settlement value with the exception of bank loans which are subsequently measured at amortised cost using the effective interest method. FRS 102 requires investments to be measured at fair value, with changes in fair value recognised in the profit or loss. The fair value was valued from documentation from the Investment broker.
2. INVESTMENT INCOME
| INVESTMENT INCOME | ||
|---|---|---|
| 2021 | 2020 | |
| £ | £ | |
| Investment income | 4,614 | - |
| Deposit account interest | 217 | 191 |
| 4,831 | 191 |
Page 16
continued...
PULMONARY HYPERTENSION ASSOCIATION UK
NOTES TO THE FINANCIAL STATEMENTS - continued FOR THE YEAR ENDED 30 APRIL 2021
3. NET INCOME/(EXPENDITURE)
Net income/(expenditure) is stated after charging/(crediting):
| 2021 | 2020 | |
|---|---|---|
| £ | £ | |
| Auditors remuneration | 5,600 | 5,600 |
| Depreciation - owned assets | 6,435 | 4,548 |
| Deficit on disposal of fixed assets | 730 | 242 |
| Auditors remuneration non audit work | 5,461 | 5,401 |
| TRUSTEES' REMUNERATION AND BENEFITS | ||
| There were no trustees' remuneration or other benefits for the year ended 30th April | 2021, nor for the year ended 30th Ap | |
| 2020. | ||
| Trustees Expenses: | ||
| 2021 | 2020 | |
| £ | £ | |
| Amounts paid to trustees | 51,473 | 50,242 |
| ====== | ====== |
4. TRUSTEES' REMUNERATION AND BENEFITS
There were no trustees' remuneration or other benefits for the year ended 30th April 2021, nor for the year ended 30th April 2020.
No grants were paid to any trustee during the year (2020 - £Nil).
No honorarium was paid to any trustee during the year (2020 - £Nil).
One trustee received £26,067 for consultancy fees in the year for services other than as a trustee, and £18,782 for secondment to the charity (2020 total - £44,725). These amounts are included in the totals above.
Trustees' expenses
Other expenses includes travel, subsistence and administrative expenses, the number of trustees reimbursed were 1.
5. STAFF COSTS
The average monthly number of employees during the year was as follows:
6.
| Administration No employees received emoluments in excess of £60,000. The salaries of key personnel in the year were £33,754 (2020 - £32,828). COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES Unrestricted funds £ INCOME AND ENDOWMENTS FROM Donations and legacies 468,949 Investment income 191 Total 469,140 EXPENDITURE ON Raising funds 42,442 Charitable activities Charitable activities 578,252 |
2021 3 Restricted funds £ 4,070 - 4,070 - 54,095 |
2020 3 Total funds £ 473,019 191 |
||
|---|---|---|---|---|
| 473,210 42,442 632,347 |
continued...
Page 17
PULMONARY HYPERTENSION ASSOCIATION UK
NOTES TO THE FINANCIAL STATEMENTS - continued FOR THE YEAR ENDED 30 APRIL 2021
| 6. COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES - continued Unrestricted Restricted funds funds £ £ Total 620,694 54,095 Net gains on investments 5,044 - NET INCOME/(EXPENDITURE) (146,510) (50,025) Transfers between funds (3,367) 3,367 Net movement in funds (149,877) (46,658) RECONCILIATION OF FUNDS Total funds brought forward 1,228,687 106,357 TOTAL FUNDS CARRIED FORWARD 1,078,810 59,699 7. TANGIBLE FIXED ASSETS Fixtures and Office fittings equipment £ £ COST At 1 May 2020 11,630 28,492 Additions 286 17,706 Disposals - (1,299) At 30 April 2021 11,916 44,899 DEPRECIATION At 1 May 2020 5,702 17,979 Charge for year 932 5,503 Eliminated on disposal - (569) At 30 April 2021 6,634 22,913 NET BOOK VALUE At 30 April 2021 5,282 21,986 At 30 April 2020 5,928 10,513 |
Total funds £ 674,789 5,044 (196,535) - (196,535) 1,335,044 1,138,509 Totals £ 40,122 17,992 (1,299) 56,815 23,681 6,435 (569) 29,547 27,268 16,441 |
|---|---|
continued...
Page 18
PULMONARY HYPERTENSION ASSOCIATION UK
NOTES TO THE FINANCIAL STATEMENTS - continued FOR THE YEAR ENDED 30 APRIL 2021
8. FIXED ASSET INVESTMENTS
| Listed | Listed | ||
|---|---|---|---|
| Investments | Investments | ||
| 2021 | 2020 | ||
| £ | £ | ||
| Market value at 1st May 2020 | 953,620 | 1,054,143 | |
| Additions | 832,450 | 52,864 | |
| Disposals | ( 839,600) | (147,339) | |
| Unrealised gains/(losses) | 251,276 | (10,557) | |
| Realised gain/(loss) | 10,505 | 4,509 | |
| ------------- | ------------- | ||
| Market value at 30th April 2021 | 1,208,251 | 953,620 | |
| ======= | ======= | ||
| Historical cost at 1st May 2020 | 636,972 | 687,500 | |
| Addition | 832,450 | 52,864 | |
| Disposals | (540,869) | (103,392) | |
| ------------- | ------------ | ||
| Historical cost at 30th April 2021 | 928,553 | 636,972 | |
| ======= | ======= | ||
| 9. | STOCKS | ||
| 2021 | 2020 | ||
| £ | £ | ||
| Stocks | 9,789 | 20,026 | |
| 10. | DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR | ||
| 2021 | 2020 | ||
| £ | £ | ||
| Trade debtors | 4,853 | 30,716 | |
| Pulmonary Hypertension | |||
| Association (UK) | 20,693 | 26,061 | |
| Accrued income | 3,378 | 5,244 | |
| Prepayments | 17,475 | 67,604 | |
| 46,399 | 129,625 | ||
| 11. | CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR | ||
| 2021 | 2020 | ||
| £ | £ | ||
| Trade creditors | 16,356 | 35,875 | |
| Social security and other taxes | 2,135 | 2,454 | |
| Accruals and deferred income | 117,271 | 74,187 | |
| 135,762 | 112,516 |
continued...
Page 19
PULMONARY HYPERTENSION ASSOCIATION UK
NOTES TO THE FINANCIAL STATEMENTS - continued FOR THE YEAR ENDED 30 APRIL 2021
12. MOVEMENT IN FUNDS
| MOVEMENT IN FUNDS | ||||
|---|---|---|---|---|
| At 1.5.20 £ Unrestricted funds General fund 178,810 Medical Research 250,000 Development and Printing of Booklets and Online content 350,000 Awareness Activities 80,000 Fundraising Activities 50,000 Contingency Fund 65,000 Patient & Peer, Education & Support Events 105,000 1,078,810 Restricted funds Living with PH 59,699 Breelib Project - 59,699 TOTAL FUNDS 1,138,509 Net movement in funds, included in the above are as follows: Incoming resources £ Unrestricted funds General fund 437,594 Medical Research 53 Development and Printing of Booklets and Online content - Awareness Activities - Fundraising Activities 14,462 452,109 Restricted funds Living with PH - Breelib Project 15,915 Lottery Grant 9,048 24,963 TOTAL FUNDS 477,072 |
Net movement in funds £ 423,850 (43,856) (62,934) (36,599) 8,599 - - 289,060 (50,918) (47,214) (98,132) 190,928 Resources expended £ (275,525) (43,909) (62,934) (36,599) (5,863) (424,830) (50,918) (63,129) (9,048) (123,095) (547,925) |
Transfers between funds £ (182,004) 43,856 62,934 36,599 (8,599) - - (47,214) - 47,214 47,214 - Gains and losses £ 261,781 - - - - 261,781 - - - - 261,781 |
At 30.4.21 £ 420,656 250,000 350,000 80,000 50,000 65,000 105,000 1,320,656 8,781 - 8,781 1,329,437 Movement in funds £ 423,850 (43,856) (62,934) (36,599) 8,599 289,060 (50,918) (47,214) - (98,132) 190,928 |
|
continued...
Page 20
PULMONARY HYPERTENSION ASSOCIATION UK
NOTES TO THE FINANCIAL STATEMENTS - continued FOR THE YEAR ENDED 30 APRIL 2021
12. MOVEMENT IN FUNDS - continued
Comparatives for movement in funds
| Unrestricted funds General fund Medical Research Annual Conference Family Weekend Development and Printing of Booklets and Online content Awareness Activities Fundraising Activities Contingency Fund PHocus 2021 Actelian Physio Project Patient & Peer, Education & Support Events Restricted funds Medical Research PH Professionals Secretariat Living with PH TOTAL FUNDS |
At 1.5.19 £ 328,687 250,000 60,000 45,000 350,000 80,000 50,000 65,000 - - - 1,228,687 102 1,272 104,983 106,357 1,335,044 |
Net movement in funds £ 63,912 32,176 (73,840) - (55,399) (70,845) (26,588) - (4,890) (11,036) - (146,510) (2,180) (2,561) (45,284) (50,025) (196,535) |
Transfers between funds £ (213,789) (32,176) 13,840 (45,000) 55,399 70,845 26,588 - 4,890 11,036 105,000 (3,367) 2,078 1,289 - 3,367 - |
At 30.4.20 £ 178,810 250,000 - - 350,000 80,000 50,000 65,000 - - 105,000 |
|---|---|---|---|---|
| 1,078,810 - - 59,699 |
||||
| 59,699 | ||||
| 1,138,509 |
Comparative net movement in funds, included in the above are as follows:
| Unrestricted funds General fund Medical Research Annual Conference Development and Printing of Booklets and Online content Awareness Activities Fundraising Activities PHocus 2021 Actelian Physio Project Restricted funds Medical Research PH Professionals Secretariat Living with PH TOTAL FUNDS |
Incoming resources £ 395,734 60,895 - - - 12,511 - - 469,140 320 3,750 - 4,070 473,210 |
Resources expended £ (336,866) (28,719) (73,840) (55,399) (70,845) (39,099) (4,890) (11,036) (620,694) (2,500) (6,311) (45,284) (54,095) (674,789) |
Gains and Movement losses in funds £ £ 5,044 63,912 - 32,176 - (73,840) - (55,399) - (70,845) - (26,588) - (4,890) - (11,036) 5,044 (146,510) - (2,180) - (2,561) - (45,284) - (50,025) 5,044 (196,535) |
Gains and Movement losses in funds £ £ 5,044 63,912 - 32,176 - (73,840) - (55,399) - (70,845) - (26,588) - (4,890) - (11,036) 5,044 (146,510) - (2,180) - (2,561) - (45,284) - (50,025) 5,044 (196,535) |
|---|---|---|---|---|
| (146,510) (2,180) (2,561) (45,284) |
||||
| (50,025) | ||||
| (196,535) |
Details of designated funds
At 30 April 2021, Pulmonary Hypertension Association UK had £900,000 of unrestricted funds currently designated as follows:
- Up to £250,000 towards the cost of academic/clinical research.
continued...
Page 21
PULMONARY HYPERTENSION ASSOCIATION UK
NOTES TO THE FINANCIAL STATEMENTS - continued FOR THE YEAR ENDED 30 APRIL 2021
12. MOVEMENT IN FUNDS - continued
Details of designated funds - continued
-
Up to £60,000 for the funding of an annual conference. Due to the changes caused by the pandemic the trustees don't think this fund will be required going forward.
-
Up to £80,000 towards the funding of awareness activities including setting up an All Parliamentary Group.
-
Up to £350,000 towards the production of educational literature and Online content including, completion of ImPAHct survey and production of newsletters with the results for medical professionals and members, Listening to me, Listening to you publication, Provision of educational resources for patients with learning disabilities, PH Medical Education Programme, Educational needs of patients and caregivers in relation to end of life care, practical aspects of daily living with PH, welfare benefit advice and the like.
-
Up to £50,000 towards fundraising activities.
-
Up to £45,000 towards the preparation and cost of the family weekend. Due to the pandemic it was not possible to arrange a family weekend in 2020 and the trustees consider this provision no-longer required.
-
Up to £65,000 as a contingency reserve.
-
Up to £105,000 towards arranging patient & peer educational and support events that can be undertaken within the constraints arising from the pandemic.
Where funds set aside for research are subsequently spent the expenditure is inclusive of both the charity's own unrestricted funds and contributions from third party partners including industry
13. OTHER FINANCIAL COMMITMENTS
Commitments under operating lease agreements.
At 30 April 2021 the charity had total commitments under non-cancellable operating leases as follows;
| 2021 | 2020 | 2020 | ||
|---|---|---|---|---|
| Other £ - 28,672 28,672 |
||||
| Land & Building |
Other | Land & Building |
||
| Expiry date: | £ | £ | £ | |
| Within 1 to 5 years | - | - | - | |
| 168,060 | 21,504 | 206,843 | ||
| 168,060 | 21,504 | 206,843 | ||
14.
RELATED PARTY DISCLOSURES
Due to the nature of the charity's operations and the composition of the Board of Trustees being drawn from local and national public and private sector organisations, it is inevitable that transactions will take place with organisations in which a member of the board of trustees may have an interest. Any such transactions are conducted at arm's length and in accordance with the charity's financial regulations and normal procurement procedures.
Details of trustee's interests are contained within the trustees report , and note 4.
On 31 July 2010 the net assets and operations of Pulmonary Hypertension Association (UK), an unincorporated charity (charity number 1082613) were transferred to the charity at net book value.
The trustees of Pulmonary Hypertension Association UK are also trustees of Pulmonary Hypertension Association (UK).
Donations totalling £214,632 were made to the charity by Pulmonary Hypertension Association (UK) (2020 - £232,489).
At 30 April 2021, £20,693 was due from Pulmonary Hypertension Association (UK) (2020 - £26,061).
continued...
Page 22
PULMONARY HYPERTENSION ASSOCIATION UK
NOTES TO THE FINANCIAL STATEMENTS - continued FOR THE YEAR ENDED 30 APRIL 2021
15. RESTRICTED FUNDS
Living with PH
Actelion Pharmaceutical provided a grant of £65,000 in 2017 and a further £42,500 in 2018 towards this survey/research project called "Living better with PH". Bayer also provided a grant of £50,000 towards this project in 2018. This is a long term project which will run over a number of years.
Breelib Project
Bayer paid to fund research project to evaluate patient experience using Breelib
Lottery Grant
Grant received from the Lottery Community Fund to assist the printing and postage of the Emphasis Autumn Magazine
Page 23